Patent intelligence · US
US 12083081
Sterile aqueous choline salt compositions
Sterile aqueous choline salt compositions
Patent details — US 12083081
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 10, 2024
- Expiration
- Sep 5, 2044
- Applicant
- PROTARA THERAPEUTICS, INC.
- Claims
- 30
- CPC classes
- A61K, A61K31/14, A61K45/06, A61K47/02
Quick answer
US 12083081 (Sterile aqueous choline salt compositions) is held by PROTARA THERAPEUTICS, INC.. Status: granted. Granted Sep 10, 2024. Expires Sep 5, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- PROTARA THERAPEUTICS, INC.
- Grant date
- Expiration
- Claims
- 30
- CPC classes
- A61K, A61K31/14, A61K45/06, A61K47/02, A61K9/0019, A61K9/08
More from PROTARA THERAPEUTICS, INC.
Related pharmaceutical patents in our USPTO index.
Related coverage
Frequently asked questions
What is US patent 12083081?
US 12083081 (Sterile aqueous choline salt compositions) is held by PROTARA THERAPEUTICS, INC.. Status: granted. Granted Sep 10, 2024. Expires Sep 5, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12083081?
PROTARA THERAPEUTICS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 12083081 expire?
Our index shows an expiration date of Sep 5, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.